Sanxin Medical (300453.SZ) released its performance for the first three quarters, with net profit attributable to shareholders of RMB 210 million, a year-on-year increase of 13.68%.

Zhitong Finance APP News, Sanxin Medical (300453.SZ) disclosed its 2026 third quarter report. In the first three quarters, the company achieved revenue of 1.305 billion yuan, a year-on-year increase of 11.78%; net profit attributable to the parent company was 210 million yuan, a year-on-year increase of 13.68%; net profit after deducting non-recurring gains and losses was 193 million yuan, a year-on-year increase of 15.59%; basic earnings per share was 0.4037 yuan.